Process for inhibiting complement activation via the alternative pathway
AssigneeGliatech, Inc.
InventorsRekha Gupta-Bansal, Kurt R. Brunden, James B. Parent
Life of this patent
Estimating the term…
Abstract
A process of inhibiting activation of complement via the alternative pathway, including inhibiting the formation of complement activation products via the alternative pathway, is provided.
Claims14
A process of inhibiting the adverse effects of alternative complement pathway activation products in a subject comprising administering to the subject an amount of anti-properdin agent effective to selectively inhibit formation of an alternative complement pathway activation product.
A process for inhibiting the adverse effects of classical complement pathway activation in a subject in which the classical complement pathway is initiated comprising administering to the subject an amount of an anti-properdin agent effective to selectively inhibit formation of an alternative complement pathway activation product.
Dependencies are inferred from the claim text.